NEW YORK (GenomeWeb News) – Strategic Diagnostics said yesterday that it will provide monoclonal antibodies for a proteomic study being conducted by Science Applications International Corporation – Frederick and the National Cancer Institute.
 
SDI’s antibodies will be used as reference reagents for the Proteomics Reagents & Resources component of the National Cancer Institute’s Clinical Proteomic Technologies for Cancer initiative.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.